C-reactive Protein Testing Market Size

C-reactive Protein Testing Market Size

C-reactive Protein Testing Market size was valued at around USD 3.2 billion in 2023 and is expected to reach around USD 4.4 billion by 2032 at a CAGR of 3.9% from 2024 to 2032. The growth of the market is being driven by the rising prevalence of chronic disorders coupled with an increased demand for CRP testing for the effective diagnosis and management of these conditions.

Chronic conditions like rheumatoid arthritis, cardiovascular diseases, and diabetes necessitate regular monitoring and management, which is facilitated by CRP testing. The rise in these chronic conditions has led to a greater reliance on CRP tests for early detection and ongoing management. For instance, according to the World Health Organization (WHO), as of 2023, chronic diseases are responsible for 71% of all deaths globally, underscoring the critical need for effective diagnostic and monitoring tools. This surge in chronic disease prevalence is thus fueling the demand for CRP testing on a global scale.
 

C-reactive protein (CRP) testing measures the level of C-reactive protein in the blood, which is produced by the liver in response to inflammation. Elevated CRP levels can indicate acute or chronic inflammation due to various conditions such as infections, autoimmune diseases, and cardiovascular diseases. The test helps diagnose and monitor inflammatory disorders, assess the severity of infections, and evaluate the risk of heart disease.